Dengue Academy is intended for an international audience of healthcare professionals outside of the US and UK.
This website has been initiated and developed by Takeda

© Copyright 2022 Takeda Pharmaceutical Company Limited. All rights reserved.
Takeda and the Takeda Logo are registered trademarks of Takeda Pharmaceutical Company Limited.
VV-MEDMAT-55340, Date of preparation: November 2021

Molecular Bio & Immunology

Dengue Virus Life Cycle

HHMI BioInteractive

4 minutes
Distinct Dengue Epidemiology and Viral Characteristics in Indonesia

ADVA

25 minutes
Reconstructing unseen transmission events to infer dengue dynamics from viral sequences

Takeda

2 minutes
Coagulation abnormalities in Dengue fever infection: A systematic review and meta-analysis

Takeda

2 minutes
A fatal case report of antibody-dependent enhancement of dengue virus type 1 following remote Zika virus infection

Takeda

2 minutes
Combination of inflammatory and vascular markers in the febrile phase of dengue is associated with more severe outcomes

Takeda

2 minutes
Dengue serotypes

Takeda

4 minutes
Dengue - unanswered scientific questions

Takeda

11 minutes
NS1 and its potential association with severe dengue

Takeda

3 minutes
Dengue virus and pathobiology

Takeda

1 minutes

Dengue Academy is intended for an international audience of healthcare professionals outside of the US and UK.
This website has been initiated and developed by Takeda

© Copyright 2022 Takeda Pharmaceutical Company Limited. All rights reserved.
Takeda and the Takeda Logo are registered trademarks of Takeda Pharmaceutical Company Limited.
VV-MEDMAT-55340, Date of preparation: November 2021